BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 27, 2013
View Archived Issues
Small-molecule antiviral agents target HIV-1 replication
Read More
AstraZeneca and Moderna Therapeutics to develop messenger RNA therapeutics
Read More
Bluebird bio enters collaboration with Celgene
Read More
H3 Biomedicine and BGI to develop and share cancer genomic sequencing data
Read More
Benefits demonstrated for onabotulinumtoxinA in patients with OAB
Read More
Novel QC inhibitor shows promise as AD therapy in a phase I trial
Read More
BioCryst Pharmaceuticals patents new tyrosine-protein kinase inhibitors
Read More
Acofide tablets approved in Japan for functional dyspepsia
Read More
Auxilium announces topline data from study of Xiaflex in frozen shoulder syndrome
Read More
TOP2A as an independent biomarker of NPC tumor aggressiveness
Read More
Inovelon approved in Japan for Lennox-Gastaut syndrome
Read More
Neuropore Therapeutics presents novel therapeutic candidate for neurological disorders
Read More
arGEN-X advances ARGX-112 into preclinical development
Read More
New agents for substance abuse and dependence divulged by Gilead Sciences
Read More
Shionogi receives approval for metreleptin in Japan
Read More
Shin Nippon Biomedical and Nagasaki University enter collaboration
Read More
Reversible covalent modification of KEAP1 as a promising approach for PD therapy
Read More
Onglyza approved in Japan for type 2 diabetes
Read More
BioCryst commences clinical study of candidate for hereditary angioedema
Read More
Lundbeck and Otsuka expand collaboration to include Lu-AE-58054
Read More
Shire gains lifitegrast with acquisition of SARcode Bioscience
Read More
Chugai gains Japanese approval for subcutaneous formulation of Actemra
Read More
Japanese authorities approve denosumab for osteoporosis
Read More
FDA approves botulism antitoxin manufactured by Cangene
Read More
GSK gives update on FDA's review of H5N1 adjuvanted influenza vaccine
Read More
Eisai set to launch neuromuscular-blocking agent in Japan for cervical dystonia
Read More
Bristol-Myers Squibb presents new series of anti-HIV agents
Read More
FDA approves Novartis' dry powder inhaled antibacterial Tobi Podhaler
Read More